Shire Plc (SHPG)

160.88
3.50 2.10
NASDAQ : Health Technology
Prev Close 164.37
Open 160.29
Day Low/High 158.50 / 161.50
52 Wk Low/High 123.73 / 192.15
Volume 1.03M
Avg Volume 1.29M
Exchange NASDAQ
Shares Outstanding 300.99M
Market Cap 51.58B
EPS 14.30
P/E Ratio 43.68
Div & Yield 1.05 (0.64%)

Latest News

Three Biotech Names to Consider

Three Biotech Names to Consider

A look at three names to consider in the biotech and biopharma space.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

Oil remained near a three-year high despite falling back slightly on Thursday.

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

M&A activity kicks into high gear going into the final days of the first quarter. If the broader stock market doesn't pop on this news, it would be a red flag.

The Dow Falls Into Wednesday's Close

The Dow Falls Into Wednesday's Close

Strength in the morning yields to weakness in the afternoon session as stocks are sold off Wednesday.

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Shire Pharmaceuticals shares hit a year-to-date high Wednesday after Japan's biggest drugmaker, Takeda, confirmed it may make a takeover approach for the U.K.-listed group.

Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates

Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates

With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.

The New #35 Most Shorted Nasdaq 100 Component: Shire

The New #35 Most Shorted Nasdaq 100 Component: Shire

The most recent short interest data has been released for the 12/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

Biotech M&A activity will pick up markedly in 2018, and these companies are likely to be the most active in that space.

10 Biotech Stocks to Watch in 2018

10 Biotech Stocks to Watch in 2018

There are a variety of players that should be active in the M&A space next year.

Roche Stock Surges on Trial Successes in Cancer, Haemophilia

Roche Stock Surges on Trial Successes in Cancer, Haemophilia

Roche sees success in trials for its cancer and hemophilia drugs

Weekly Roundup

The markets' climb hits a detour at the end of the week. In the portfolio, after adding five names to the bullpen, we promoted one of them to the portfolio.

Billionaire Hedge Fund Manager Leon Cooperman Gave His Top 5 Cheap Stocks

Billionaire Hedge Fund Manager Leon Cooperman Gave His Top 5 Cheap Stocks

Cooperman founded Omega Advisers in 1991.

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Evercore ISI analyst Josh Schimmer is bullish on biotech.

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

A number of biotech-related stocks were down pre-market after announcing plans for public offerings.

Shire Gains as it Seeks European Approval For Dry Eye Treatment

Shire Gains as it Seeks European Approval For Dry Eye Treatment

The drug would be the first such treatment in Europe.

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

The labor market goes under inspection and Apple releases its earnings report.

Shire Stock Rising on Takeover Talks

Shire Stock Rising on Takeover Talks

Shire is also said to have hired its own defense advisers to ward off low bids.

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

Here are the activist investor's next potential targets.

Jana Partners Liquidates Whole Foods Stake After Engineering Industry-Transforming Sale To Amazon

Jana Partners Liquidates Whole Foods Stake After Engineering Industry-Transforming Sale To Amazon

The activist will gain $320 million on the sale, which suggests that the fund either doesn't believe a higher bidder is coming or that they need the cash.

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run

Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run

Big gains could be ahead for investors willing to stick with the stock, according to one firm.

Biotech Movers: Shire, Bellicum, Organovo

Biotech Movers: Shire, Bellicum, Organovo

Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.

TheStreet Quant Rating: C (Hold)